The developmental toxicity of ethylene oxide (EtO) was examined in Sprague-Dawley rats following inhalation exposure during Days 6 to 15 of gestation. Two different exposure regimens were used: (1) exposure for 0.5 hr once a day to 0, 400, 800, or 1200 ppm EtO; or (2) exposure for 0.5 hr three times a day to 0, 200, or 400 ppm EtO or 0, 800, or 1200 ppm EtO. Repeated brief exposures (3 x 0.5 hr/day) to EtO caused fetal toxicity indicated by reduced fetal weight at 800 and 1200 ppm, and overt maternal toxicity manifested as reduced body weight gain at 1200 ppm. Neither embryolethality nor teratogenicity occurred following any exposure regimen. © 1996 Society of Toxicology.
Ethylene oxide (EtO) is an intermediate in the chemical industry and is widely used for the sterilization of medical supplies in hospitals and in the medical products industry.
The developmental toxicity of EtO has been evaluated in various laboratory species (rats, mice, rabbits) using intravenous or inhalation routes of exposure (for review, Florack and Zielhuis, 1990) . Intravenous administration of EtO to rabbits throughout a substantial part of organogenesis was shown to cause some embryolethal effects at a dose of 150 mg/kg, which also produced maternal toxicity (Kimmel etal., 1982) . In mice, intravenous administration of 150 mg/kg EtO was reported to increase the incidence of skeletal malformations after treatment on gd 6-8 and to increase the incidence of resorptions after treatment on gd 8-10 or 10-12 (La Borde and Kimmel, 1980) . Inhalation exposure of pregnant animals to EtO gave no evidence of teratogenic effects in either rats or rabbits. Hackett et al. (1982) observed a reduction of fetal weight together with delayed ossification in litters from rats exposed 7 hr/day to the maternal toxic concentration of 150 ppm EtO from gd 1 to 16 or gd 7 to 16. In the same study, no sign of maternal or embryo-fetal toxicity was found in rabbits ' To whom correspondence should be addressed.
inhaling 150 ppm EtO throughout major organogenesis (7 hr/day, gd 1-19 or 7-19). In another inhalation study, rats were exposed to 10, 33, or 100 ppm EtO during organogenesis (6 hr/day, gd 6-15). Decreased fetal body weight was observed at 100 ppm in the absence of significant maternal toxicity (Snellings et al., 1982) .
Reports on EtO exposure in sterilization areas depict a broad range of high and short-term exposure levels with relatively low and long-term background levels (Mouilleseaux et al., 1983; Elliott et al., 1988; NIOSH, 1989) . Exposure of workers to high concentrations may occur during the removal of the load from the sterilizer on completion of the sterilization cycle and during the transfer of a freshly sterilized article from the sterilization chamber to aeration rooms. Exposures are mainly dependent on work practices and the existence of engineering controls (e.g., local ventilation). Peak levels of up to 500 ppm have been reported (Florack and Zielhuis, 1990; Elias et al., 1993) . In the available inhalation studies, animals were exposed to EtO for 6 or 7 hr per day and several authors have stressed the need for developmental toxicity studies including peak exposures (Hardin et al, 1983; Florack and Zielhuis, 1990) . Thus, this study was initiated to provide information on the developmental toxicity of EtO in rats following high and shortduration inhalation exposures.
MATERIAL AND METHODS

Animals.
Male (350 g) and primiparous female (200-180 g) SpragueDawley (OFA) rats were supplied by Iffa Credo Breeding Laboratories (Saint-Germain-sur-l'Abresle, France). Animals were acclimatized to our animal quarters for 1 to 2 weeks prior to breeding, in rooms designed to control temperature at 22 ± 1°C, relative humidity at 55 ± 5%, and a light cycle from 7 AM to 7 PM. Female rats were then placed with males (one male:three females) overnight and were examined by vaginal smear for the presence of sperm the following morning.
Sperm-positive females were considered gd 0. They were randomly assigned to treatment groups so that mean body weights on gd 6 were the same across groups.
Exposure conditions. Exposure was conducted in 200-liter stainlesssteel inhalation chambers with dynamic and adjustable laminar air flow (5-10 mVhr). In order to prevent any leakage of the test atmospheres, the chambers were maintained at a negative pressure of no more than 3 mm water. The chamber temperature was set at 23 ± 1°C and the relative humidity at 55 ± 5%. EtO vapor was delivered from a compressed gas cylinder containing 2% EtO and 98% air (Air Liquide, France) via a pressure-regulating valve. This EtO-air mixture was diluted with filtered air before entry of the stream into the exposure chamber. Flow rates of EtO and air were measured and adjusted by rotameters in order to achieve the target concentrations.
EtO concentrations within each chamber were regularly measured during animal exposures by pumping a measured volume of atmosphere through a glass tube packed with activated charcoal. The absorbent was then desorbed with carbon disulfide and the resulting samples were analyzed by gas-liquid chromatography (Greff et al, 1986) . In addition, levels of exposure were continuously adjusted with a gas-liquid chromatograph equipped with an automatic gas sampling valve. Six minutes was the theoretical time taken, given the chamber size and air flow rate, for the chamber atmosphere to reach 95% of the target concentration (f95) (Silver, 1946) .
Because the concentrations determined by analyses were essentially the same as the target concentrations, the target concentrations will be referred to throughout this paper (Table 1) .
Experimental design. Bred rats were exposed to EtO by inhalation on Days 6 through 15 of gestation. In the first series of experiments (single short-duration exposure), animals were exposed for 0.5 hr once a day to 0, 400, 800, or 1200 ppm EtO. In another series (repeated short-duration exposures), animals were exposed three times a day to 0, 200, or 400 ppm EtO or to 0, 800, or 1200 ppm EtO.
Exposures were conducted at the same time every day and at regular intervals between 8 AM and 4 PM for the repeated 0.5-hr exposures.
Maternal and fetal observations. All rats were observed daily throughout pregnancy and maternal body weights were recorded on gd 0, 6, 11, 16, and 21. On gd 21, the females were euthanized by an intrapulmonary injection of T 6 | (Hoechst AG, Frankfurt, FRG). The uterus was removed and weighed. The uterine horns were then opened, and the number of implantation and resorption sites and live and dead fetuses was recorded. Live fetuses were removed from the uterus, blotted free of excess fluids and weighed, examined for external alterations including those of the oral cavity, and the sex was determined by external examination. One-half of the live fetuses in each litter was preserved in Bouin's solution and examined for soft-tissue alterations using the free-hand razor blade sectioning techniques of Barrow and Taylor (thorax and abdomen; 1969) and Wilson (craniofacial structures; 1965) . The remaining half of the fetuses was fixed in 70% ethanol and subsequently eviscerated, macerated in 1% KOH, stained in alizarin red S (Staples and Schnell, 1964) , and examined microscopically for skeletal alterations. Fetal alterations were defined as malformations (rare and/or lethal) or developmental variations (deviations from normal that are not uncommon at examination).
Statistical analysis. Whenever possible, the data were presented as means ± SD. The number of implantation sites and live fetuses and various body weights were analyzed by one-way analysis of variance, followed by Dunnett's test if differences were found. The frequency of nonsurviving implants, resorptions, and anomalies among litters was evaluated using the Wilcoxon test after an arc-sine-square root transformation. Rates of pregnancy and fetal sex ratio were analyzed using Fisher's test. Where applicable, least-squares analysis was carried out. The reported level of statistical significance wasp < 0.05. The litter was used as the experimental unit for analysis of fetal variables. •o V ft.
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RESULTS
Single Short-Duration Exposure (1 X 0.5 hr/Day) on Gestation Days 6-15
The death of one pregnant female was observed at 800 ppm after the exposure period was over. Except for a significant increase between gd 6 and 11 at 400 and 800 ppm EtO (p < 0.05), there were no differences between control and EtO groups in the maternal weight gain throughout gestation (Table 2) . No adverse effects on the pregnancy rate, average number of implantations and live fetuses, incidence of nonsurviving implants or resorptions or fetal sex ratio were noted among litters exposed to EtO (Table 3 ). Male and female body weights were comparable among groups. No external or skeletal malformations were observed in treated or control groups (Table 4) . Single occurrences of soft-tissue malformations including hydronephrosis and interventricular septum defect were observed in groups receiving EtO. There was a statistically significant increase in the percentage of fetuses per litter with soft-tissue variations at 400 and 1200 ppm. Analyses of individual soft-tissue variations indicated a statistically significant increase in two common variations, dilated renal pelvis and ureter, only in the 1200-ppm group (p < 0.01). The incidence of skeletal variations in total or by category was similar in all groups of fetuses.
Repeated Short-Duration Exposures (3 X 0.5 hr/Day) on Gestation Days 6-15
In the first set of experiments, rats were exposed to 0, 3 X 200, or 3 x 400 ppm EtO. All animals survived the exposure. No statistically significant effects on maternal weight gain during gestation and on absolute weight gain were discerned among dams exposed to EtO when compared to the corresponding control ( Table 2 ). The pregnancy rates were comparable across groups (Table 3 ). The number of implantation sites and of live fetuses and the incidence of nonsurviving implants and resorptions were not significantly different from the concurrent control values. The male and female fetal body weights which were significantly reduced at 3 X 200 ppm relative to the control were within our historical control range. A dose-response was not observed. This finding was not considered of toxicological significance but rather interpreted to be attributable to the unusually high fetal weight (along with a low number of live fetuses) in the concurrent control group. The reason for these changes in the control values could not be ascertained. Major malformations were seen in one fetus from the control group (interventricular septum defect) and in three fetuses from three litters exposed to 3 X 400 ppm (two cases of interventricular septum defect and one of unilateral hydronephrosis). Several common external, visceral, and skeletal variations were ob- (20) 4 (3) 2.6 ± 6.7 0 1 (1) 3 (2) 28 (12) 18.1 i 21.0 0 0 17 (9) 18 (10) 147 ( (8) 13.0 ± 16.9 0 (I 7(6) 14 (7) 136 ( f Approximately 50% of each litter was examined for soft-tissue defects.
* Incidence of fetuses with unilateral or bilateral defects combined. * Approximately 50% of each litter was examined for skeletal defects after staining with alizarin red S.
*• ** Significant differences from the concurrent control (0 ppm) value, p < 0.05 and p < 0.01, respectively.
served with no indication of adverse effects due to EtO exposure (Table 4) . In the second set of experiments rats were exposed to 0, 3 X 800 or 3 X 1200 ppm EtO. There were no maternal deaths. The maternal weight gain during gd 6 to 21 and the absolute weight gain were significantly less than the concurrent control at the highest concentration (p < 0.01) ( Table 2 ). These differences were due to a significant decrease in the mean body weight gain throughout the treatment (gd 6-11 and 11-16) (p < 0.01). Pregnancy rates, numbers of implantation sites, resorptions and live fetuses, and fetal sex ratios did not differ statistically between EtOexposed and control groups (Table 3) . A significant decrease in male and female fetal weights was observed in both EtOexposed groups (p < 0.01), which was more pronounced at 3 X 1200 ppm than 3 X 800 ppm. No external or skeletal malformations were noted. Soft-tissue malformations occurred occasionally in one or a few fetuses in the control and/or treated groups (Table 4) . They consisted of folded retina, interventricular septum defect, and unilateral hydronephrosis. The incidence of external, visceral, and skeletal variations was scattered with no indication of adverse effects in any of the exposed groups when compared to the control.
DISCUSSION
Our results show that a daily 0.5-hr exposure to up to 1200 ppm EtO produced neither signs of maternal toxicity nor adverse effects on embryo-fetal development with the exception of an increase in two minor soft-tissue variations (dilated renal pelvis and ureter). This observation was not borne out after repeated brief exposures at this high concentration in additional experiments and is probably of little toxicological significance.
Three daily 0.5-hr exposures to 800 or 1200 ppm EtO resulted in developmental toxicity as evidenced by a significant decrease in fetal body weights. These fetal effects appeared in the absence of overt maternal toxicity. No other signs of embryo/fetotoxicity were seen. Significant maternal toxicity was evident among dams exposed to 1200 ppm three times per day and was expressed as marked decreases in weight gain throughout the exposure period and in absolute weight gain.
Despite obvious maternal toxicity, no evidence of teratogenicity or embryotoxicity was observed in the current study. These findings confirm those of previous inhalation studies in which EtO was fetotoxic and nonteratogenic in rats exposed to 150 ppm EtO 7 hr/day (Hackett et al, 1982) or to 100 ppm EtO 6 hr/day during gestation (Snellings et al., 1982) . Hackett et al. (1982) also observed an increased incidence of resorptions in litters from rats exposed to 150 ppm EtO before breeding and during gestation (gd 1-16).
In conclusion, EtO produced slight developmental toxicity in rats after repeated short-duration exposures at levels up to and including 1200 ppm during major organogenesis.
